UniProt ID | ARI2_HUMAN | |
---|---|---|
UniProt AC | O95376 | |
Protein Name | E3 ubiquitin-protein ligase ARIH2 | |
Gene Name | ARIH2 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 493 | |
Subcellular Localization | Nucleus . Cytoplasm . | |
Protein Description | E3 ubiquitin-protein ligase, which catalyzes ubiquitination of target proteins together with ubiquitin-conjugating enzyme E2 UBE2L3. [PubMed: 16118314] | |
Protein Sequence | MSVDMNSQGSDSNEEDYDPNCEEEEEEEEDDPGDIEDYYVGVASDVEQQGADAFDPEEYQFTCLTYKESEGALNEHMTSLASVLKVSHSVAKLILVNFHWQVSEILDRYKSNSAQLLVEARVQPNPSKHVPTSHPPHHCAVCMQFVRKENLLSLACQHQFCRSCWEQHCSVLVKDGVGVGVSCMAQDCPLRTPEDFVFPLLPNEELREKYRRYLFRDYVESHYQLQLCPGADCPMVIRVQEPRARRVQCNRCNEVFCFKCRQMYHAPTDCATIRKWLTKCADDSETANYISAHTKDCPKCNICIEKNGGCNHMQCSKCKHDFCWMCLGDWKTHGSEYYECSRYKENPDIVNQSQQAQAREALKKYLFYFERWENHNKSLQLEAQTYQRIHEKIQERVMNNLGTWIDWQYLQNAAKLLAKCRYTLQYTYPYAYYMESGPRKKLFEYQQAQLEAEIENLSWKVERADSYDRGDLENQMHIAEQRRRTLLKDFHDT | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
44 | Phosphorylation | DYYVGVASDVEQQGA HHEEEEECCHHHCCC | 39.52 | 26074081 | |
85 | Ubiquitination | TSLASVLKVSHSVAK HHHHHHHHHHHHHHH | 39.26 | - | |
113 | Phosphorylation | LDRYKSNSAQLLVEA HHHHHCCCCEEEEEE | 25.20 | 27251275 | |
259 | Ubiquitination | CNEVFCFKCRQMYHA CCCEEEEECCEECCC | 29.68 | - | |
279 | Ubiquitination | TIRKWLTKCADDSET HHHHHHHHHCCCHHH | 25.84 | - | |
289 | Phosphorylation | DDSETANYISAHTKD CCHHHHHHHHHCCCC | 8.19 | 27642862 | |
295 | Ubiquitination | NYISAHTKDCPKCNI HHHHHCCCCCCCCCE | 47.68 | - | |
299 | Ubiquitination | AHTKDCPKCNICIEK HCCCCCCCCCEEEEE | 46.36 | - | |
335 | Phosphorylation | GDWKTHGSEYYECSR CCCCCCCCCCCCCCC | 18.15 | 28152594 | |
337 | Phosphorylation | WKTHGSEYYECSRYK CCCCCCCCCCCCCCC | 13.27 | 28152594 | |
338 | Phosphorylation | KTHGSEYYECSRYKE CCCCCCCCCCCCCCC | 13.35 | 28152594 | |
341 | Phosphorylation | GSEYYECSRYKENPD CCCCCCCCCCCCCCC | 27.06 | 28152594 | |
344 | Ubiquitination | YYECSRYKENPDIVN CCCCCCCCCCCCCCC | 50.32 | 21906983 | |
353 | Phosphorylation | NPDIVNQSQQAQARE CCCCCCHHHHHHHHH | 21.03 | 17525332 | |
364 | Ubiquitination | QAREALKKYLFYFER HHHHHHHHHHHHHHH | 48.30 | 21906983 | |
377 | Ubiquitination | ERWENHNKSLQLEAQ HHHHHCCHHHHHHHH | 45.02 | 21906983 | |
392 | Ubiquitination | TYQRIHEKIQERVMN HHHHHHHHHHHHHHH | 35.21 | - | |
419 | Ubiquitination | NAAKLLAKCRYTLQY HHHHHHHHHCCEEEE | 21.15 | - | |
422 | Phosphorylation | KLLAKCRYTLQYTYP HHHHHHCCEEEECCC | 22.67 | 24043423 | |
423 | Phosphorylation | LLAKCRYTLQYTYPY HHHHHCCEEEECCCC | 6.50 | 24043423 | |
426 | Phosphorylation | KCRYTLQYTYPYAYY HHCCEEEECCCCEEE | 16.02 | 24043423 | |
427 | Phosphorylation | CRYTLQYTYPYAYYM HCCEEEECCCCEEEE | 12.69 | 24043423 | |
428 | Phosphorylation | RYTLQYTYPYAYYME CCEEEECCCCEEEEC | 6.85 | 24043423 | |
430 | Phosphorylation | TLQYTYPYAYYMESG EEEECCCCEEEECCC | 9.23 | 24043423 | |
432 | Phosphorylation | QYTYPYAYYMESGPR EECCCCEEEECCCCC | 9.48 | 24043423 | |
433 | Phosphorylation | YTYPYAYYMESGPRK ECCCCEEEECCCCCH | 6.04 | 24043423 | |
436 | Phosphorylation | PYAYYMESGPRKKLF CCEEEECCCCCHHHH | 37.25 | 24043423 | |
441 | Ubiquitination | MESGPRKKLFEYQQA ECCCCCHHHHHHHHH | 60.74 | 21890473 | |
460 | Ubiquitination | EIENLSWKVERADSY HHHHHCEEEEECCCC | 30.73 | 21906983 | |
466 | Phosphorylation | WKVERADSYDRGDLE EEEEECCCCCCCCHH | 28.13 | 20873877 | |
467 | Phosphorylation | KVERADSYDRGDLEN EEEECCCCCCCCHHH | 15.37 | 20873877 | |
488 | Ubiquitination | QRRRTLLKDFHDT-- HHHHHHHHHHCCC-- | 62.55 | - |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of ARI2_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of ARI2_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"ATM and ATR substrate analysis reveals extensive protein networksresponsive to DNA damage."; Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III,Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N.,Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J.; Science 316:1160-1166(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-353, AND MASSSPECTROMETRY. |